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A B S T R A C T
Limbic encephalitis (LE) can be either paraneoplastic or a non-paraneoplastic autoimmune disorder.
Magnetic resonance imaging (MRI) of the brain on T2-weighted ﬂuid-attenuated inversion recovery
(FLAIR) classically shows hyperintensities of the temporal structures, but multifocal involvement of
extratemporal cortex has also been described in paraneoplastic LE. Here we describe a 27-year-old
womanwhose idiopathic autoimmune (glutamic acid decarboxylase-antibody positive) LE debutedwith
multiple daily mesio-temporal seizures, amnesia and multifocal extratemporal cortical MRI
abnormalities. Mesio-temporal MRI signal increase was found after 20 days. This case report highlights
that early diagnosis of non-paraneoplastic LE may be considered in patients with multiple daily mesio-
temporal seizures and amnesia even in the absence of early typical MRI abnormalities.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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It is now accepted that limbic encephalitis (LE) can be
paraneoplastic or non-paraneoplastic.1–3 In non-paraneoplastic
cases, high serum levels of voltage-gated potassium channels
(VGKC) antibodies (Abs)2,3 have been found, aswell as Abs directed
against glutamic acid decarboxylase (GAD),4 N-methyl-D-aspar-
tate (NMDA) receptor/channel or to unknown antigens.5 The
typical clinical presentation of idiopathic LE is a subacute onset of
confusion, anterograde amnesia, temporal lobe seizures and
behavioral changes. Magnetic resonance imaging (MRI) of the
brain on T2-weighted ﬂuid-attenuated inversion recovery (FLAIR)
shows hyperintensities with swelling usually restricted to the
mesio-temporal cortex, with late atrophy and occasional involve-
ment of other temporal structures.6,7 Extratemporal cortical
involvement has been reported only in patients with paraneo-
plastic LE.8–11 Here we describe a young woman whose idiopathic
autoimmune LE debuted with mesio-temporal seizures associated
with multifocal cortical extratemporal abnormalities.* Corresponding author at: Centro Regionale Epilessie, Presidio Riuniti, Via
Melacrino, 89100, Reggio Cal., Italy. Tel.: +39 333 3167327; fax: +39 0965 397973.
E-mail address: u.aguglia@tin.it (U. Aguglia).
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doi:10.1016/j.seizure.2010.06.0022. Case report
A 27-year-old woman with no family or personal history of
epilepsy or febrile convulsions presented at the emergency room
because of daily episodes of funny feelings four days after a febrile
episode. At admission to neurology department, she was
diagnosed of mesio-temporal lobe epilepsy with multiple daily
seizures. In the past history, she had depression, anxiety treated
with antidepressants, and autoimmune Hashimoto’s thyroiditis
diagnosed at the age of 24 and treated for 11 months with
corticosteroids that were stopped 18 months before. Her interictal
neurological examination was normal. The neuropsychological
examination included Raven’s coloured progressive matrices
[score = 23.5, normal value (n.v.) > 17.5], immediate and delayed
recall of a short story (score = 4, n.v. > 6.5), thirty paired word
associates (score = 4, n.v. >6.5), semantic verbal ﬂuency test
(score = 36, n.v. > 17), phonemic verbal ﬂuency test (score = 31,
n.v. > 25), and revealed severe impairment of recentmemory, with
preservation of language functions. The interictal EEG showed
spike-waves over the right temporal lobe (Fig. 1a). Ictal video-EEG
monitoring showed seizure pattern consisting of temporo-parietal,
rhythmic theta waves followed by epigastric aura (Fig. 1b), and
spiking activity and diffuse fast rhythms associated with fear,
ﬂushing, diaphoresis and de´ja`-vu without loss of consciousness orvier Ltd. All rights reserved.
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Fig. 1. EEG at admission to neurology department; (a) interictal EEG. Note spike-waves over the right temporal lobe; (b)–(d) ictal EEG. Note disappearance of the alpha activity
and presence of rhythmic theta waves on leads P4, T4 and T6. Epigastric aura occurred six sec after onset (b). Spikes and spiking activity on leads T6, P4, F8 and T4 and diffuse
fast (13–16 Hz) rhythms were associated with fear, ﬂushing, diaphoresis and de´ja`-vu (c) and (d); (e) end of the seizure (40 s after (d)). There was no loss of consciousness
during the seizure.
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sometimes amnesia followed the seizures. Visual and somatosen-
sory evoked potentials were normal. Routine laboratory analyses
were normal (including glucose), but the sodium level was low
126 mEq/L (n.v. 135–145). Cerebrospinal ﬂuid (CSF) analysisshowed the presence of oligoclonal bands, with normal protein
and cellular content. No serum antibodies against onconeural
antigens were found. PCR ampliﬁcation for herpes simplex virus
(HSV) on CSF, serum antibodies to herpes simplex virus (HSV),
human herpes virus (HHV)-6 and HHV-7, extensive serum tests for
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(Carcinoembryonic antigen, alpha-fetoprotein, Ca125, Ca19-9,
Ca15-3), Anti-Nuclear-Abs, antibodies to Extractable-Nuclear-
Antigen, cytoplasmic-Antineutrophil Cytoplasmic-Abs (cANCA),
perinuclear-ANCA, anti-transglutaminase-Abs and anti-gliadin-
Abs were negative or normal. At that time, no serum reactivity to
VGKC-Abs or to the NR1/NR2 heteromers of the NMDA receptor/
channel was detected (A.V.), whereas a radioimmunoprecipitation
assay evaluation of stored serum and CSF collected at entry
demonstrated very high levels of anti-GAD-Abs in the serum
(6000 U/ml normal value < 1.0 U/ml) and in CSF (120 U/ml,
normal value: < 1 U/ml). The anti-GAD intrathecal synthesis index
[CSF anti-GAD IgG value/serum anti-GAD value]/[CSF albumin/
serum albumin], (positive value > 1) was positive (value: 7.7).
Thyroid hormoneswere also normal, while high serum titer of both
antithyroid microsomal (424 IU/ml, n.v. < 50) and antithyroid
peroxidase (3334 IU/ml: n.v. < 60) antibodies were at lower levels
than 30 months previously (anti-microsomal-Abs: 800 IU/ml;
anti-peroxidase-Abs: 4585 IU/ml). Whole-body CT, including
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Fig. 2. MRI (FLAIR-sequences). At entry (a)–(c): note two small intracortical lesions loca
fronto-basal cortex of the left hemisphere (6 mm: (c)). No abnormalities were observ
extratemporal cortical lesions (d) and (e) with bilateral hyperintensity and swelling of th
immunotherapy (g)–(i) persistence of hyperintensity of the mesial temporal lobe on thbrain, did not show any abnormality. On admission, 2 days after
the onset of illness, T2, FLAIR, and diffusion-weighted brain MRI
sequences showed two small hyperintensity areas localized in the
parietal cortex of the right hemisphere and in the fronto-basal
cortex of the left hemisphere, with no contrast enhancement.
Surprisingly, no abnormalities were observed in the temporal
lobes (Fig. 2a–c) at this time, but a second MRI performed 20 days
later showed typical bilateral swelling with hyperintensity (with
no contrast enhancement) of the mesial temporal lobes bilaterally,
but more evident on the right side, as well as persistence of the
extratemporal lesions (Fig. 2d–f). The patient was treated with
anti-epileptic medication (topiramate 200 mg/day) and i.v. meth-
ylprednisolone (1 g/day for ﬁve consecutive days). One week after
steroid treatment, the seizures were reduced in frequency and
duration, the interictal EEG was normal and MRI showed only the
persistence of hyperintensity over the right mesial temporal lobe
(Fig. 2g–i). The patient was discharged with anticonvulsant
therapy only. However, at follow-up (1, 2 and 3 months after
the end of immunotherapy) she still had severe impairment of thelized in the parietal cortex of the right hemisphere (10 mm: (a) and (b)) and in the
ed in the temporal lobes. Twenty days after admission (d)–(f): persistence of the
e mesial temporal lobes (more evident on the right side: (e) and (f). Seven days after
e right side and disappearance of the other lesions.
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resistant to anti-epileptic treatment, but she refused treatment
with i.v. immunoglobulins or oral steroids. Six months after onset,
a repeated MRI was unchanged (showing only right temporal lobe
signal abnormality, without hippocampal atrophy) and whole-
body PET scan was normal. Treatment with oral prednisone
(50 mg/day) was then accepted. Six months after onset of oral
prednisone, neurological and psychometric evaluations were
unchanged.
3. Discussion
Here, we have described a patient with clinical, laboratory and
imaging features of LE, including a subacute amnesic syndrome
with mesio-temporal seizures, hyponatremia, high levels of anti-
GAD-Abs and temporomedial T2/FLAIR signal increase. The failure
to demonstrate an occult tumor on whole-body PET and the
absence of any clinical and laboratory evidence of paraneoplastic
antibodies suggested a non-paraneoplastic, idiopathic condi-
tion.2,3,7 The patient’s serum was negative for VGKC-Abs but
strongly positive for GAD-Abs; antibodies to GAD are typically
found in stiff-person syndrome, but are increasingly recognized as
amarker for other autoimmune CNS conditions such as cerebellar
ataxia, palatal tremor, focal epilepsy and occasionally LE.4 LE
patients with GAD-Abs may evolve into a refractory temporal
lobe epilepsy.12–14 Temporomedial T2/FLAIR signal increase is
usually considered the MRI hallmark of both idiopathic and
paraneoplastic LE1–12 and may be associated with extratemporal
signal abnormalities in paraneoplastic LE.8–11 In non-paraneo-
plastic LE, however, extratemporal lesions are rare although they
have been reported in the subcortical white matter15 or the basal
ganglia16 at the same time as the temporomesial lesions. Normal
MRI has also been reported in patients with non-paraneoplastic
anti-GAD LE4.
EEG is a sensitive investigation in paraneoplastic LE: slow-wave
abnormalities are seen in most cases, and focal epileptiform
abnormalities are documented in about 50% of the patients17. Focal
epileptiform abnormalitieswere recorded in our patient at onset of
LE. Interestingly, ictal clinical manifestations suggested a restrict-
ed (temporomesial) symptomatogenic zone,18 while ictal EEG
recordings documented a wide (fronto-temporo-parietal) seizure-
onset zone18 over the right hemisphere. These ﬁndings, along with
imaging data, demonstrated that the cortical damage was more
diffuse than expected by clinical symptomatology.
In conclusion, the interesting feature of this youngwomanwith
high GAD-Abs is that her symptoms followed a ﬂu-like episode and
were initially associated with frequent mesio-temporal seizuresand multifocal extratemporal cortical abnormalities, in the
absence of typical limbic lesions seen on MRI at onset of disease.
Besides in patients with LE with classic MRI features, GAD-Abs
should also be assayed in patients with subacute onset of amnesic
syndrome, temporomesial seizures and extratemporal MRI abnor-
malities.
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